Field testing of World Health Organization (WHO) 2003 recommendations for initiating anti-retroviral therapy (ART) where CD4 is not available revealed low sensitivity among stage I and II patients; a combination of Automated Total Lymphocyte Count (TLC) and Haemoglobin (Hgb) can ration the referral for CD4 testing.

dc.creator	Chan, Keith
dc.creator	Tu, D
dc.creator	Klarkowski, D
dc.creator	O'Brien, Daniel P
dc.creator	Mills, C
dc.creator	Elema, R
dc.creator	Verputten, M
dc.creator	Bedell, R
dc.creator	Olaiya, M
dc.creator	Braker, K
dc.creator	Shanks, L
dc.creator	Hogg, R
dc.date	2006
dc.date.accessioned	2017-01-31T07:11:23Z
dc.date.available	2017-01-31T07:11:23Z
dc.identifier	http://hdl.handle.net/10144/29481
dc.identifier	http://fieldresearch.msf.org/msf/handle/10144/29481
dc.identifier.uri	http://dspace.mediu.edu.my:8181/xmlui/handle/10144/29481
dc.description	2006 AIDS Conference, Toronto
dc.language	en
dc.title	Field testing of World Health Organization (WHO) 2003 recommendations for initiating anti-retroviral therapy (ART) where CD4 is not available revealed low sensitivity among stage I and II patients; a combination of Automated Total Lymphocyte Count (TLC) and Haemoglobin (Hgb) can ration the referral for CD4 testing.

Files in this item

Files	Size	Format	View
There are no files associated with this item.